iBIONICS Teams Up with University of Ottawa SUNLAB

[fa icon="calendar"] Aug 23, 2016


The Diamond Eye Project has Exciting New Collaboration with University of Ottawa


Ottawa, Canada, August 23, 2016 - iBIONICS has announced that they have chosen the SUNLAB, part of the Centre for Research in Photonics at the University of Ottawa, one of the foremost photonics centres in the world, for collaboration in developing the wireless capability to transfer data and power for their Diamond Eye solution to blindness. This will be accomplished with the development of a high efficiency photovoltaic (PV) cell.


“This a very exciting project for us. We have the expertise needed to help iBIONICS reach their goals,” says Dr Karin Hinzer, director of the SUNLAB. “One of the aims of the SUNLAB is to help entrepreneurs solve problems. We really want to get this research off the shelf and into the real world, to benefit the visually-impaired.


The SUNLAB is led by Dr Karin Hinzer, PhD, PEng, Canada Research Chair in Photonic Nanostructures and Integrated Devices, and Associate Professor at the School of Electrical Engineering and Computer Science. She brings with her Dr. John Cook, PhD, Senior Research Associate at the SUNLAB.


”The talent behind the SUNLAB is phenomenal,” says Michel Pigeon, iBIONICS Cofounder and Chief Operating Officer. “The University of Ottawa team has the capability, knowledge and entrepreneurial willingness to step into the Diamond Eye project. This collaboration is great news for iBIONICS going forward.”


“The PV cell takes light and electrical power, and transforms photons into electricity. This makes the Diamond Eye surgery much faster and simpler,” asserts Dr Flavio Rezende, iBIONICS’ Chief Medical Officer. “It will revolutionize how we perform some types of retinal surgery. By having a higher voltage, we can now place the implant on top of the retina instead of burying it sub-retinally. This advantage cannot be overstated.”





iBIONICS is a born global health innovation startup with headquarters in Ottawa and Gatineau, Canada and operations in Melbourne, Australia. iBIONICS delivers health solutions by designing, manufacturing and commercializing implantable bionic solutions that treat debilitating diseases. The iBIONICS Diamond Eye restores vision enabling the blind to regain autonomy, recognize faces and read large print. The iBIONICS Diamond Eye uses diamond electrodes to stimulate the retina, sending messages to the brain perceived as light. This leading technology designed to return autonomy and partial vision to the blind is supported by a state-of-the-art wireless solution for implantable bionic devices developed in Canada.


To learn more about the University of Ottawa’s Centre for Research in Photonics or IBIONICS, please contact: suzanne@ibionics.ca, 613-697-8818


Topics: News release